Unknown

Dataset Information

0

Effect of a Low-Calorie Diet on Restoration of Normoglycemia in Obese subjects with Type 2 Diabetes.


ABSTRACT:

Introduction

Type 2 diabetes mellitus (T2DM) is considered to be an inevitably progressive disease. Complex therapies add to the financial and psychological burden. Very low-calorie diets (LCDs) are emerging as an option in the management of type 2 diabetes.

Methods

We performed a clinical audit of patients with T2DM who received 12 weeks of LCD.

Results

This case series documents that 6 out of 12 participants (median baseline HbA1c 9%) achieved HbA1c level in nondiabetes range with LCD despite stopping all antidiabetes medications. There was an improvement in serum triglycerides, HDL cholesterol, total cholesterol, C-Reactive protein, urine microalbumin, liver transaminases, liver fat and the indices of insulin resistance, beta cell secretory capacity, and insulin sensitivity.

Conclusion

If long-term follow-up proves sustained benefits, such dietary restriction may be an alternative to more drastic options for reversal of type 2 diabetes. This may also help in changing the treatment perspective of a newly detected T2DM from an incurable and inevitably progressive disease to a potentially reversible disease.

SUBMITTER: Bhatt AA 

PROVIDER: S-EPMC5628553 | biostudies-literature | 2017 Sep-Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of a Low-Calorie Diet on Restoration of Normoglycemia in Obese subjects with Type 2 Diabetes.

Bhatt Anjali Amit AA   Choudhari Priya K PK   Mahajan Rutuja R RR   Sayyad Mehmood G MG   Pratyush Devi D DD   Hasan Imtiaz I   Javherani Rajesh S RS   Bothale Manish M MM   Purandare Vedavati B VB   Unnikrishnan Ambika Gopalakrishnan AG  

Indian journal of endocrinology and metabolism 20170901 5


<h4>Introduction</h4>Type 2 diabetes mellitus (T2DM) is considered to be an inevitably progressive disease. Complex therapies add to the financial and psychological burden. Very low-calorie diets (LCDs) are emerging as an option in the management of type 2 diabetes.<h4>Methods</h4>We performed a clinical audit of patients with T2DM who received 12 weeks of LCD.<h4>Results</h4>This case series documents that 6 out of 12 participants (median baseline HbA1c 9%) achieved HbA1c level in nondiabetes r  ...[more]

Similar Datasets

| S-EPMC3404899 | biostudies-literature
| S-EPMC8146720 | biostudies-literature
| S-EPMC6418422 | biostudies-literature
| S-EPMC5816424 | biostudies-literature
| S-EPMC9610133 | biostudies-literature
| S-EPMC5762419 | biostudies-literature
| S-EPMC8703721 | biostudies-literature
| S-EPMC6835835 | biostudies-literature
| S-EPMC8006681 | biostudies-literature
| S-EPMC5002412 | biostudies-literature